Hinduja Global Solutions (HGS) Q4 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 23/24 earnings summary
2 Nov, 2026Executive summary
FY2024 operating revenue rose 2.5% YoY to ₹4,615.7 crore; operating EBITDA increased 45.8% to ₹355.9 crore, with margin up 230 bps to 7.7%.
Q4 operating revenue grew 2.7% to ₹1,098.7 crore; operating EBITDA rose 82.5% to ₹66.2 crore, with a 6.0% margin.
Priorities include AI- and analytics-led CX, HGS Agent X, GenAI deployments, cybersecurity, broadband and enterprise services, and expanded sales capacity in North America, the UK and Australia.
Financial highlights
FY2024 total income increased 1.6% to ₹5,087.8 crore; total EBITDA grew 11.0% to ₹828.0 crore, with a 16.3% margin versus 14.9%.
FY2024 PBT was ₹110.48 crore; PAT from continuing operations was ₹131.2 crore, down 54.5%, with FY2023 results including discontinued-operations profits and larger tax reversals.
Q4 total income was ₹1,257.9 crore, up 7.7%; total EBITDA rose 67.4% to ₹225.4 crore. PAT reached ₹87.9 crore versus ₹25.7 crore, alongside a ₹46.5 crore tax credit.
FY2024 other income declined as FX gains fell from ₹57 crore to ₹20 crore and property-sale gains were lower; Q4 other income rose 62% YoY.
Outlook and guidance
Management expects growth to improve from FY24, citing an encouraging pipeline and strengthened sales teams in North America, the UK and Australia.
Cape Town operations are planned to serve clients primarily in the UK, US and Australia; the South Africa subsidiary was incorporated in March 2024.
Priorities include industry-specific AI, automation and cloud solutions, horizontal CX offerings, and collaboration across BPM and media businesses.
Broadband strategy pairs subscriber growth with higher ARPU through IPTV, OTT aggregation and other services; digital services are expected to grow organically and inorganically.
Latest events from Hinduja Global Solutions
- Q2 operating EBITDA rose 30% as cost discipline offset muted growth.HGS
Q2 23/24 - Q3 EBITDA surged and PBT turned positive amid digital growth and uncertain demand.HGS
Q3 23/24 - One-time costs pressured margins; healthcare-sale gain lifted PAT, with recovery expected from Q2.HGS
Q1 24/25 - UK and macro headwinds cut revenue as technology and AI initiatives advanced.HGS
Q2 24/25 - FY25 PAT included a healthcare-sale gain as strategy pivots to AI-led digital growth.HGS
Q4 24/25 - Q3 EBITDA margin reached 19% as AI-led growth advanced amid near-term revenue pressure.HGS
Q3 24/25 - Margin expansion and digital traction amid softer Q1 revenue.HGS
Q1 25/26 - FY26 EBITDA fell 20.1%; record wins and Project GANGA support growth prospects.HGS
Q4 25/26 - Revenue held broadly steady as continuing losses widened; client wins and Project GANGA advanced.HGS
Q1 26/27